Pharmacological and biochemical actions of simple coumarins: Natural products with therapeutic potential

General Pharmacology

Volumn 27, Issue 4, 1996, Pages 713-722

  Hoult, J R S ^a   Payá, Miguel ^a,b  

^a KING'S COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF VALENCIA   (Spain)

Author keywords

Anti inflammatory drugs; Antioxidants; Arachidonic acid metabolites; Coumarins; Natural products; Radical scavengers; Reactive oxygen species; Reduction of lymphoedema; Smooth muscle relaxation

Indexed keywords

4 METHYLDAPHNETIN; 4 METHYLESCULETIN; 5,7 DIHYDROXY 4 METHYLCOUMARIN; CLORICROMEN; COUMARIN; COUMARIN DERIVATIVE; FRAXETIN; OSTHOLE; SCOPARONE; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD CLOT LYSIS; DRUG COST; DRUG MECHANISM; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERCHOLESTEROLEMIA; LIPID PEROXIDATION; LYMPHEDEMA; NONHUMAN; PRIORITY JOURNAL; RAT; THROMBOSIS;

EID: 0030176193     PISSN: 03063623     EISSN: None     Source Type: Journal    
DOI: 10.1016/0306-3623(95)02112-4     Document Type: Article

References (70)

1. Aporti F., Finesso M. and Granata L. (1987) Effect of 8-monochloro-3-β-diethylaminoethyl-4-methyl-7ethoxycarbonylmethoxycoumarin (AD6) on coronary circulation in the dog. Pharmacol. Res. Commun. 10, 467-477.
2. 2-Radikalfangereigenschaften. Arch. Pharm.(Weinheim) 313, 330-337.
3. Bertocchi F., Brevirario F., Proserpio P., Ming Wang J., Ghezzi P., Travagli R. A., Prosdocimi M. and Dejana E. (1989) In vitro inhibition of human polymorphonuclear cell function by cloricromene. N.S. Arch. Pharmacol. 339, 697-703.
4. Casley-Smith J. R. and Casley-Smith J. R. (1986) High protein oedemas and the benzopyrones. J. B. Lippincott, Sydney.
5. Casley-Smith J. R. and Casley-Smith J. R. (1992) Modern treatment of lymphoedema II. The benzopyrones. Austral. J. Dermatol. 33, 69-74.
6. Casley-Smith J. R., Földi-Börcsök E. and Földi M. (1973) The electron microscopy of the effect of treatment with coumarin (Venalot) and by thoracic duct cannulation on thermal injuries. Br. J. Exp. Pathol. 54, 1-5.
7. Casley-Smith J. R., Földi-Börcsök E. and Földi M. (1974) Fine structural aspects of lymphoedema in various tisues and the effect of treatment with coumarin and troxerutin. Br. J. Exp. Pathol. 55, 89-93.
8. Casley-Smith J. R. and Gaffney R. M. (1981) Excess plasma proteins as a cause of chronic inflammation and lymphoedema: quantitative electron microscopy. J. Pathol. 133, 69-74.
9. Casley-Smith J. R., Jamal S. and Casley-Smith J. R. (1993a) Reduction of filiaritic lymphoedema and elephantiasis by 5,6 benzo-α-pyrone (coumarin), and the effects of diethylcarbamazine (DEC). Ann. Trop. Med. Parasitol. 8, 247-258.
10. Casley-Smith J. R., Morgan R. G. and Piller N. B. (1993b) Treatment of lymphedema of the arms and legs with by 5,6 benzo-[α]-pyrone. N. Engl. J. Med. 329, 1158-1163.
11. Casley-Smith J. R. and Piller N. B. (1974) The pathogenesis of oedemas and the therapeutic action of coumarin and related compounds. Fol. Angiolog. 3, Suppl. 33-37.
12. Casley-Smith J. R., Wang C.-T., Casley-Smith J. and Zi-hai C. (1993c) Treatment of filiarial lymphoedema and elephantiasis with 5,6 benzo-α-pyrone (coumarin). Br. Med. J. 307, 1037-1041.
13. Casley-Smith J. R. and Window J. (1976) Quantitative morphological correlations of alterations in capillary permeability, following histamine and oderate burning, in the mouse diaphragm, and the effects of benzopyrones. Microvasc. Res. 11, 279-305.
14. Chang H. M., and But P. H. (1986) Pharmacology and Application of Chinese Materia Medica, p. 896. World Scientific Publishing, Singapore.
15. Clodius L. and Piller N. B. (1982) The conservative treatment of post-mastectomy in patients with coumarin results in a marked continuous reduction in swelling. In Advances in Lymphology (Edited by Bartos V. and Davidson J. W.) pp. 471-474. Avicenum, Prague.
16. Craven P. A., Pfanstiel J. and De Rubertis F. R. (1986) Role of reactive oxygen in bile salt stimulation of colonic epithelial proliferation. J. Clin. Invest. 77, 850-859.
17. Darvill A. G. and Albersheim P. (1984) Phytoalexins and their elicitors - A defense against microbial infection in plants. Annu. Rev. Plant Physiol. 35, 243-275.
18. Das N. P. and Ratty A. K. (1986) Effects of flavonoids on induced non-enzymic lipid peroxidation. Prog. Clin. Biol. Med. 213, 243-247.
19. Egan D., O'Kennedy R., Moran E., Cox C., Prosser E. and Thornes R. D. (1990) The pharmacology, metabolism, analysis and applications of coumarin and coumarin-related compounds. Drug Metab. Rev. 22, 503-529.
20. Emerit J. and Chaudière J. (1989) Free radicals and lipid peroxidation in cell pathology. In Handbook of Free Radicals and Antioxidants in Biomedicine (Edited by Miquel J., Quintanilha A. T. and Weber H.) Vol. 1, pp. 177-185. CRC Press, Boca Raton.
21. Földi-Börcsök E., Bedall F. K. and Rahlfs V. W. (1971) Die Antiphlogistiche and Ödemhemmende Wirkung von Coumarin aus Meliotis officinalis. Arzneim.-Forsch. (Drug Res). 21, 2025-2030.
22. Gresele P., Ribaldi E., Mezzasoma A. M., Quero E., Stasi M., Prosdocimi M., Goracci G. and Nenci G. G. (1993) Cloricromene inhibits leukotriene formation by human polymorphonuclear leucocytes by suppressing arachidonate release from membrane phospholipids. Biochem. Pharmacol. 45, 123-130.
23. Halliwell B., Gutteridge J. M. C. and Cross C. E. (1992) Free radicals, antioxidants and human disease: Where are we now? J. Lab. Clin. Med. 119, 598-620.
24. Harding V. K. and Heale J. B. (1980) Isolation and identification of the antifungal compounds accumulating in the induced resistance response of carrot slices to Botrytis cinerea. Physiol. Plant Pathol. 17, 277-289.
25. Hardt T. J. and Ritschel W. A. (1983) Investigation of the dose-response relationship upon intraperitoneal administration of coumarin and 7-hydroxycoumarin on the carrageenan-induced edema of the rats hind paw. Arzneim.-Forsch. (Drug Res). 33, 1662-1666.
26. Hazleton L. W., Tusing T. W., Zeitlin B. R., Theissen R. and Murer H. K. (1956) Toxicity of coumarin. J. Pharmacol. Exp. Ther. 118, 348-358.
27. Hoult J. R. S., Forder R. A., de las Heras B., Lobo I. B. and Payá M. (1994) Inhibitory activity of a series of coumarins on leukocyte eicosanoid generation. Agents Actions 42, 44-49.
28. Huang H.-C., Chu S. H. and Lee Chao P. D. (1991) Vasorelaxants from Chinese herbs, emodin and scoparone, possess immunosuppressive properties. Eur. J. Pharmacol. 198, 211-213.
29. Huang H.-C., Huang Y.-L., Chang J.-L., Chen C.-C. and Lee Y.-T. (1992a) Possible mechanism of immunosuppressive effect of scoparone (6,7-dimethoxycoumarin). Eur. J. Pharmacol. 217, 143-148.
30. Huang H.-C., Lee C.-R., Weng Y.-I., Lee M.-C. and Lee Y.-T. (1992b) Vasodilator effect of scoparone (6,7-dimethoxycoumarin) from a Chinese herb. Eur. J. Pharmacol. 218, 123-128.
31. Huang H.-C., Weng Y.-I., Lee C.-R, Jan T.-R., Chen Y.-L. and Lee Y.-T. (1993) Protection by scoparone against the alterations of plasma lipoproteins, vascular morphology and vascular reactivity in hyperlipidaemic diabetic rabbit. Br. J. Pharmacol. 110, 1508-1514.
32. Johnson A. E. (1983) Photosensitizing toxins from plants and their biologic effects. In Plant and Fungal Toxins (Handbook of Natural Toxins, volume 1), Chapter 11 (Edited by Keeler R. F. and Tu A. T.) pp. 345-359. Marcel Dekker, New York.
33. Kendall S., Towart R. and Michel C. C. (1993) Effects of hydroxyethylrutosides on the permeability of microvessels in the frog mesentery. Br. J. Pharmacol. 110, 199-206.
34. Kimura Y., Okuda H., Arichi S., Baba K. and Kozawa M. (1985) Inhibition of the formation of 5-hydroxy-6,8,11,14-eicosatetraenoic acid from arachidonic acid in polymorphonuclear leukocytes by various coumarins. Biochim. Biophys. Acta 834, 224-229.
35. Ko F.-N., Wu T.-S., Liou M.-J., Huang T.-F. and Teng C.-M. (1989) Inhibition of platelet thromboxane formation and phosphoinositides breakdown by osthole from Angelica pubescens. Thromb. Haemost. 62, 996-999.
36. Ko F.-N., Wu T.-S., Liou M.-J., Huang T.-F. and Teng C.-M. (1992) Vasorelaxation of rat thoracic aorta caused by osthole isolated from Angelica pubescens. Eur. J. Pharmacol. 219, 29-34.
37. Kozawa T., Sakai K., Uchida M., Okuyama T. and Shibata S. (1981) Calcium antagonistic action of a coumarin isolated from "Qian-Hu", a Chinese traditional medicine. J. Pharm. Pharmacol. 33, 317-320.
38. Laughton M. J., Evans P. J., Moroney M. A., Hoult J. R. S. and Halliwell B. (1991) Inhibition of mammalian 5-lipoxygenase and cyclo-oxygenase by flavonoids and phenolic dietary additives. Relationship to antioxidant activity and to iron ion-reducing ability. Biochem. Pharmacol. 42, 1673-1681.
39. Lee R. E., Bykadi G. and Ritschel W. A. (1981) Inhibition of prostaglandin biosynthesis by coumarin, 4-hydroxycoumarin and 7-hydroxycoumarin. Arzneim-Forsch (Drug Res.) 31, 640-642.
40. Levine W. G. (1970) Anticoagulants. Heparin and oral anticoagulants. In The Pharmacological Basis of Therapeutics. Fourth Ed. Chapter 65 (Edited by Goodman L. S. and Gilman A.) pp. 1445-1463. Macmillan, New York.
41. coh substrate specificity by a mutation of a single amino-acid residue. Nature 339, 632-634.
42. Maddi V., Raghu K. S. and Rao M. N. A. (1992) Synthesis and anti-inflammatory activity of 3-(benzylideneamino)coumarins in rodents. J. Pharm. Sci. 81, 964-966.
43. Mora A., Payá M., Ríos J. L. and Alcaraz M. J. (1990) Structure-activity relationships of polymethoxyflavones and other flavonoids as inhibitors of non-enzymic lipid peroxidation. Biochem. Pharmacol. 40, 793-797.
44. Moran E., O'Kennedy R. and Thornes R. D. (1987) Analysis of coumarin and its urinary metabolites by high-performance liquid chromatography. J. Chromatogr. 416, 165-169.
45. Murray R. D. H., Méndez J. and Brown R. A. (1982) The Natural Coumarins. John Wiley and Sons, New York.
46. Murray R. D. H. (1989) Coumarins. Nat. Prod. Rep. 8, 591-624.
47. Murray R. D. H. (1991) Coumarins. In Progress in the Chemistry of Organic Natural Products, vol. 58 (Edited by Herz W., Kirby G. W., Steglich W. and Tamm C.) pp. 84-316. Springer-Verlag, New York.
48. Namba T., Morita O., Huang S.-L., Goshima K., Hattori M. and Kakiuchi N. (1988) Studies on cardio-active crude drugs I. Effect of coumarins on cultured myocardial cells. Planta Med. 54, 277-282.
49. 15a as a coumarin 7-hydroxylase. Biochemistry 28, 4169-4172.
50. Neichi T., Koshilara Y. and Murota S. I. (1983) Inhibitory effect of esculetin on 5-lipoxygenase and leukotriene biosynthesis. Biochim. Biophys. Acta 753, 130-132.
51. Ojewole J. A. and Adesina S. K. (1983) Mechanism of hypotensive effect of scopoletin isolated from the fruit of Tetrapleura tetraptera. Planta Med. 49, 46-50.
52. Okuyama T., Kawasaki C., Shibata S., Hoson M., Kawada T., Osada H. and Noguchi T. (1986) Effects of oriental plant drugs on platelet aggregation II. Effect of Quian-Hu coumarins on human platelet aggregation. Planta Med. 52, 132-134.
53. Palmgren M. S. and Ciegler A. (1983) Aflatoxins. In Plant and Fungal Toxins (Handbook of Natural Toxins, vol. 1), Chapter 8 (Edited by Keeler R. F. and Tu A. T.) pp. 299-323. Marcel Dekker, New York.
54. Payá M., Halliwell B. and Hoult J. R. S. (1992a) Interactions of a series of coumarins with reactive oxygen species. Scavenging of superoxide, hypochlorous acid and hydroxyl radicals. Biochem. Pharmacol. 44, 205-214.
55. Payá M., Halliwell B. and Hoult J. R. S. (1992b) Peroxyl radical scavenging by a series of coumarins. Free Rad. Res. Comms. 17, 293-298.
56. Payá M., Goodwin P. A., de las Heras B. and Hoult J. R. S. (1994) Superoxide scavenging activity in leukocytes and absence of cellular toxicity of a series of coumarins. Biochem. Pharmacol. 48, 445-451.
57. Piller N. B. (1975) A comparison of the effectiveness of some anti-inflammatory drugs on thermal oedema. Br. J. Exp. Path. 56, 554-560.
58. Piller N. B., Morgan R. G. and Casley-Smith J. R. (1988) A double-blind cross-over trial of O-(β-hydroxyethyl)-rutosides (benzo-pyrones) in the treatment of lymphoedema of the arms and legs. Br. J. Plast. Surg. 41, 20-27.
59. Porcellati S., Constantini V., Prosdocimi M., Stasi M., Pistolesi R., Nenci G. G. and Goracci G. (1990) The coumarin derivative AD6 inhibits the release of arachidonic acid by interfering with phospholipase A2 activity in human platelets stimulated with thrombin. Agents Actions 29, 364-373.
60. Prosdocimi M., Finesso M., Tessari F., Gorio A., Languino L. R., de Gaetano G. and Dejana E. (1985) Inhibition by AD6 (8-monochloro-3-β-diethylaminoethyl-4-methyl-7-ethoxycarbonylmethoxycoumarin) of platelet aggregation in dog stenosed artery. Thromb. Res. 39, 399-409.
61. Prosdocimi M., Zatta A., Gorio A., Zanetti A. and Dejana E. (1986) Action of AD6 (8-monochloro-3-β-diethylaminoethyl-4-methyl-7-ethoxycarbonylmethoxycoumarin) on human platelets in vitro. N.S. Arch. Pharmacol. 332, 305-310.
62. Ritschel W. A. (1984) Therapeutic concentration of coumarin and predicted dosage regimens. Arzneim. Forsch. (Drug Res). 34, 907-909.
63. Ritschel W. A., Brady M. E. and Tan H. S. I. (1979) First-pass effect of coumarin in man. Int. J. Clin. Pharmacol. Biopharm. 17, 99-103.
64. Sekiya K., Okuda K. and Arichi S. (1982) Selective inhibition of platelet lipoxygenase by esculetin. Biochim. Biophys. Acta 713, 68-72.
65. Shilling W. H., Crampton R. F. and Langland R. C. (1969) Metabolism of coumarin in man. Nature 221, 664-665.
66. Superchi S., Pini D., Salvadori P., Marinelli F., Rainaldi G., Zanelli U. and Nuti-Ronchi V. (1993) Synthesis and toxicity to mammalian cells of the carrot dihydroisocoumarins. Chem. Res. Toxicol. 6, 46-49.
67. Teng C.-M., Lin C-H., Ko F.-N., Wu T.-S. and Huang T.-F. (1994) The relaxant action of osthole isolated from Angelica pubescens in guinea-pig trachea. N-S Arch. Pharmacol. 349, 202-208.
68. Thastrup O., Fjalland B. and Lemmich J. (1983) Coronary vasodilatory, spasmolytic and cAMP phosphodiesterase inhibitory properties of dihydropyranocoumarins and dihydrofuranocoumarins. Acta Pharmacol. Toxicol. 52, 246-253.
69. Thastrup O., Knudsen J. B., Lemmich J. and Winther K. (1985) Inhibition of human platelet aggregation by dihydropyrano- and dihydrofurano-coumarins, a new class of cAMP phosphodiesterase inhibitors. Biochem. Pharmacol. 34, 2137-2140.
70. Yamada M., Hearse D. J. and Curtis M. J. (1990) Reperfusion and readmission of oxygen. Pathophysological relevance of oxgyen-derived free radicals to arrhythmogenesis. Circ. Res. 67, 1211-1224.